Description
The vector of anti-GLRB chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target Human GLRB. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-GLRB antibody linked to CD28 and CD3ζ signaling domains. And the vector product was designed for the treatment of Prostate cancer